Can Oncotype DX recurrence score (RS) be used in Luminal A and Luminal B breast cancer patients (pts) to predict the likely benefit of chemotherapy? A retrospective unicentric study in Spanish population.
Laura G. Estevez
No relevant relationships to disclose
Isabel Calvo
No relevant relationships to disclose
Maria Fernandez-Abad
No relevant relationships to disclose
Juan Jose Cruz
No relevant relationships to disclose
Ana Suarez
No relevant relationships to disclose
Fernando Lopez-Rios
No relevant relationships to disclose
Manuel Hidalgo
No relevant relationships to disclose